BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16606836)

  • 1. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.
    Raivio T; Sidis Y; Plummer L; Chen H; Ma J; Mukherjee A; Jacobson-Dickman E; Quinton R; Van Vliet G; Lavoie H; Hughes VA; Dwyer A; Hayes FJ; Xu S; Sparks S; Kaiser UB; Mohammadi M; Pitteloud N
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4380-90. PubMed ID: 19820032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.
    Quinton R; Duke VM; Robertson A; Kirk JM; Matfin G; de Zoysa PA; Azcona C; MacColl GS; Jacobs HS; Conway GS; Besser M; Stanhope RG; Bouloux PM
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):163-74. PubMed ID: 11531922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characteristics of Novel FGFR1 Mutations in Patients with Isolated Gonadotropin-Releasing Hormone Deficiency.
    Choi JH; Oh A; Lee Y; Kim GH; Yoo HW
    Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):457-463. PubMed ID: 32485746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational Modification Defects in Fibroblast Growth Factor Receptor 1 as a Reason for Normosmic Isolated Hypogonadotropic Hypogonadism.
    Ying H; Sun Y; Wu H; Jia W; Guan Q; He Z; Gao L; Zhao J; Ji Y; Li G; Xu C
    Oxid Med Cell Longev; 2020; 2020():2358719. PubMed ID: 33299522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A female patient with normosmic idiopathic hypogonadotropic hypogonadism carrying a novel mutation in FGFR1.
    Wang XL; Wang DD; Gu JQ; Zhang N; Shan ZY
    Genet Mol Res; 2014 Nov; 13(4):9472-6. PubMed ID: 25501157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians.
    Nair S; Jadhav S; Lila A; Jagtap V; Bukan A; Pandit R; Ekbote A; Dharmalingam M; Kumar P; Kalra P; Gandhi P; Walia R; Sankhe S; Raghavan V; Shivane V; Menon P; Bandgar T; Shah N
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):100-9. PubMed ID: 26708526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
    Xu N; Qin Y; Reindollar RH; Tho SP; McDonough PG; Layman LC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1155-8. PubMed ID: 17200176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH).
    Koika V; Varnavas P; Valavani H; Sidis Y; Plummer L; Dwyer A; Quinton R; Kanaka-Gantenbein C; Pitteloud N; Sertedaki A; Dacou-Voutetakis C; Georgopoulos NA
    Gene; 2013 Mar; 516(1):146-51. PubMed ID: 23276709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Quinton R; Pearce S; Raivio T; Acierno J; Dwyer A; Plummer L; Hughes V; Seminara S; Cheng YZ; Li WP; Maccoll G; Eliseenkova AV; Olsen SK; Ibrahimi OA; Hayes FJ; Boepple P; Hall JE; Bouloux P; Mohammadi M; Crowley W
    J Clin Invest; 2007 Feb; 117(2):457-63. PubMed ID: 17235395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
    Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
    PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on the variants of FGFR1 and CEP290 genes in idiopathic hypogonadotropin hypogonadism.
    Wang SS; Zhao WY; Wu HX; Shu M; Yuan JX; Fang L; Xu C
    Yi Chuan; 2022 Oct; 44(10):937-949. PubMed ID: 36384729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.